天合光能(688599.SH):擬授予激勵對象限制性股票3000萬股
格隆匯 12 月 8日丨天合光能(688599.SH)發佈2020年限制性股票激勵計劃(草案),擬授予激勵對象的限制性股票數量為3000萬股,佔公告日公司股本總額的1.45%。其中,首次授予限制性股票2400萬股,佔公告日公司股本總額的1.16%,佔擬授予限制性股票總數的80%;預留600萬股,佔公告日公司股本總額的0.29%,預留部分佔擬授予限制性股票總數的20%。
首次授予限制性股票的授予價格為每股10.26元,即滿足授予條件和歸屬條件後,激勵對象可以每股10.26元的價格購買公司股票。
該激勵計劃涉及的激勵對象共計479人,佔公司截止2019年12月31日員工總數12743的3.76%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.